Most common adverse reactions in controlled studies include (incidence ≥5% over placebo):
• Adults: blurred vision, somnolence, dizziness, abnormal coordination, tremor, and fatigue.
• Pediatric patients (3 to 16 years of age): weight gain
• Somnolence, bronchitis, ear infection, and acute otitis media.
from FDA,2021.10
Sabril (vigabatrin) is an antiepileptic drug used for the treatment of refractor···【more】
Release date:2026-03-03Recommended:25